Phase 2 Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a specific type of blood cancer called AML (acute myeloid leukemia), except for two particular subtypes known as Philadelphia chromosome-positive AML and acute promyelocytic leukemia (AML M3)
- People aged 18 or older
- People whose general health and ability to carry out daily activities meets a certain minimum level, as measured by a standard medical scale called the ECOG scale (score of 3 or below) (confirm with trial site)
- People whose AML has not responded to a specific combination treatment called venetoclax plus azacitidine (VEN-AZA) after at least two rounds of that treatment
- People who have signed a form confirming they understand and agree to take part in the trial
- People who are covered by a social security or health insurance system (this requirement appears to relate to the French healthcare system) (confirm with trial site)
Who may not be able to join:
- People whose condition means a doctor could prescribe them another targeted therapy that already has official regulatory approval
- People whose cancer has spread to the brain or spinal cord
- People who have heart failure
- People who have liver failure
- People who have kidney failure
- People who have a medical reason they cannot take a drug called dasatinib
- People who have HIV with a detectable viral load, or who have active Hepatitis B or Hepatitis C
- People who are pregnant or breastfeeding
- Women of childbearing age who are not using an effective form of contraception
- People who are in an emergency medical situation or who are unable to give informed consent
- People who are under a legal protection arrangement, such as guardianship or curatorship
- People who are unable to attend the required medical follow-up appointments due to geographic, social, or psychological reasons
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +33491223778
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
tumor response
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.